ACP
APLT

Acuta Capital Partners’s Applied Therapeutics APLT Stock Holding History

Acuta Capital Partners’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-792,000
Closed -$5.39M – 34
2024
Q1 		$5.39M Buy
792,000
+266,900
+51% +$1.2M 3.5% 10
2023
Q4 		$1.76M Buy
+525,100
New +$1.31M 0.99% 27
2020
Q3 		– Sell
-182,000
Closed -$6.58M – 47
2020
Q2 		$6.58M Buy
182,000
+80,000
+78% +$3.35M 1.9% 21
2020
Q1 		$3.33M Sell
102,000
-46,000
-31% -$1.86M 1.62% 22
2019
Q4 		$4.04M Buy
148,000
+65,000
+78% +$1.11M 1% 24
2019
Q3 		$912K Buy
+83,000
New +$783K 0.66% 28

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acuta Capital Partners's APLT Position: Q2 2024 in Review

Acuta Capital Partners sold out of Applied Therapeutics (APLT) in Q2 2024, closing a stake of 792,000 shares — an estimated $5.39M sold.

Acuta Capital Partners first reported a position in APLT in Q3 2019 and held it in 6 quarters. The position peaked at $6.58M in Q2 2020. 94 funds tracked by Wall St. Rank hold APLT as of Q2 2024.

  • Acuta Capital Partners reported no remaining Applied Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Acuta Capital Partners sold 792,000 Applied Therapeutics shares in Q2 2024, an estimated $5.39M.
  • Acuta Capital Partners first reported a position in Applied Therapeutics in Q3 2019 and held it in 6 quarters.
  • Acuta Capital Partners's Applied Therapeutics position peaked at $6.58M in Q2 2020.
  • 94 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2024.

Based on Acuta Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.